Inflammatory response time course, HUVEC (Wada et al., 2009)
Name | miRBASE accession |
---|---|
hsa-miR-19a-3p
|
MIMAT0000073 |
hsa-miR-19b-3p
|
MIMAT0000074 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_64211112 | 6.27 |
ENST00000295902.6
|
PRICKLE2
|
prickle homolog 2 (Drosophila) |
chr1_+_84543734 | 5.16 |
ENST00000370689.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr1_+_61547894 | 4.96 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr4_+_41362796 | 4.83 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr18_-_22932080 | 4.81 |
ENST00000584787.1
ENST00000361524.3 ENST00000538137.2 |
ZNF521
|
zinc finger protein 521 |
chr9_-_14314066 | 4.31 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr18_+_8717369 | 4.22 |
ENST00000359865.3
ENST00000400050.3 ENST00000306285.7 |
SOGA2
|
SOGA family member 2 |
chr17_+_68165657 | 4.14 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
chr7_-_11871815 | 4.10 |
ENST00000423059.4
|
THSD7A
|
thrombospondin, type I, domain containing 7A |
chr4_-_149365827 | 3.96 |
ENST00000344721.4
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
chr6_-_16761678 | 3.89 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
chr8_-_93115445 | 3.89 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr7_-_27183263 | 3.71 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr12_+_79258547 | 3.68 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr8_-_22550815 | 3.35 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
chr9_+_2015335 | 3.28 |
ENST00000349721.2
ENST00000357248.2 ENST00000450198.1 |
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr4_+_134070439 | 3.26 |
ENST00000264360.5
|
PCDH10
|
protocadherin 10 |
chr4_+_55524085 | 3.23 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
chr2_-_86094764 | 3.05 |
ENST00000393808.3
|
ST3GAL5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
chr13_-_107187462 | 2.91 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
chr7_+_89841000 | 2.90 |
ENST00000287908.3
|
STEAP2
|
STEAP family member 2, metalloreductase |
chr4_+_87856129 | 2.85 |
ENST00000395146.4
ENST00000507468.1 |
AFF1
|
AF4/FMR2 family, member 1 |
chr1_+_25943959 | 2.75 |
ENST00000374332.4
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
chr7_-_132261253 | 2.72 |
ENST00000321063.4
|
PLXNA4
|
plexin A4 |
chr7_+_114562172 | 2.52 |
ENST00000393486.1
ENST00000257724.3 |
MDFIC
|
MyoD family inhibitor domain containing |
chr6_+_15246501 | 2.45 |
ENST00000341776.2
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chr1_+_92495528 | 2.42 |
ENST00000370383.4
|
EPHX4
|
epoxide hydrolase 4 |
chr2_+_189156389 | 2.39 |
ENST00000409843.1
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1 |
chr2_-_240322643 | 2.29 |
ENST00000345617.3
|
HDAC4
|
histone deacetylase 4 |
chr3_+_124223586 | 2.22 |
ENST00000393496.1
|
KALRN
|
kalirin, RhoGEF kinase |
chr6_+_136172820 | 2.20 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
chr3_+_194406603 | 2.18 |
ENST00000329759.4
|
FAM43A
|
family with sequence similarity 43, member A |
chr5_-_90679145 | 2.18 |
ENST00000265138.3
|
ARRDC3
|
arrestin domain containing 3 |
chr3_-_18466787 | 2.12 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
chr9_-_140196703 | 2.08 |
ENST00000356628.2
|
NRARP
|
NOTCH-regulated ankyrin repeat protein |
chr19_+_34745442 | 2.05 |
ENST00000299505.6
ENST00000588470.1 ENST00000589583.1 ENST00000588338.2 |
KIAA0355
|
KIAA0355 |
chr12_-_59313270 | 2.05 |
ENST00000379141.4
|
LRIG3
|
leucine-rich repeats and immunoglobulin-like domains 3 |
chr6_-_111136513 | 2.04 |
ENST00000368911.3
|
CDK19
|
cyclin-dependent kinase 19 |
chr3_-_124774802 | 2.03 |
ENST00000311127.4
|
HEG1
|
heart development protein with EGF-like domains 1 |
chr9_-_80646374 | 1.95 |
ENST00000286548.4
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide |
chr17_+_65821780 | 1.91 |
ENST00000321892.4
ENST00000335221.5 ENST00000306378.6 |
BPTF
|
bromodomain PHD finger transcription factor |
chr1_+_82266053 | 1.90 |
ENST00000370715.1
ENST00000370713.1 ENST00000319517.6 ENST00000370717.2 ENST00000394879.1 ENST00000271029.4 ENST00000335786.5 |
LPHN2
|
latrophilin 2 |
chrX_+_46433193 | 1.89 |
ENST00000276055.3
|
CHST7
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 |
chr1_+_212458834 | 1.87 |
ENST00000261461.2
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha |
chr8_-_124553437 | 1.77 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
chr2_-_101767715 | 1.75 |
ENST00000376840.4
ENST00000409318.1 |
TBC1D8
|
TBC1 domain family, member 8 (with GRAM domain) |
chr5_-_100238956 | 1.74 |
ENST00000231461.5
|
ST8SIA4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
chr5_-_73937244 | 1.74 |
ENST00000302351.4
ENST00000510316.1 ENST00000508331.1 |
ENC1
|
ectodermal-neural cortex 1 (with BTB domain) |
chr8_-_4852218 | 1.68 |
ENST00000400186.3
ENST00000602723.1 |
CSMD1
|
CUB and Sushi multiple domains 1 |
chr14_+_37667118 | 1.64 |
ENST00000556615.1
ENST00000327441.7 ENST00000536774.1 |
MIPOL1
|
mirror-image polydactyly 1 |
chr5_-_107006596 | 1.60 |
ENST00000333274.6
|
EFNA5
|
ephrin-A5 |
chr6_+_16129308 | 1.59 |
ENST00000356840.3
ENST00000349606.4 |
MYLIP
|
myosin regulatory light chain interacting protein |
chr13_+_80055284 | 1.59 |
ENST00000218652.7
|
NDFIP2
|
Nedd4 family interacting protein 2 |
chr8_-_103668114 | 1.56 |
ENST00000285407.6
|
KLF10
|
Kruppel-like factor 10 |
chr11_+_92085262 | 1.54 |
ENST00000298047.6
ENST00000409404.2 ENST00000541502.1 |
FAT3
|
FAT atypical cadherin 3 |
chr1_+_12227035 | 1.54 |
ENST00000376259.3
ENST00000536782.1 |
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B |
chrX_+_118108571 | 1.53 |
ENST00000304778.7
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
chr11_-_19263145 | 1.52 |
ENST00000532666.1
ENST00000527884.1 |
E2F8
|
E2F transcription factor 8 |
chr22_-_39548627 | 1.51 |
ENST00000216133.5
|
CBX7
|
chromobox homolog 7 |
chrX_-_74376108 | 1.49 |
ENST00000339447.4
ENST00000373394.3 ENST00000529949.1 ENST00000534524.1 ENST00000253577.3 |
ABCB7
|
ATP-binding cassette, sub-family B (MDR/TAP), member 7 |
chr4_+_145567173 | 1.49 |
ENST00000296575.3
|
HHIP
|
hedgehog interacting protein |
chr2_-_39664405 | 1.48 |
ENST00000341681.5
ENST00000263881.3 |
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3 |
chr2_+_28615669 | 1.46 |
ENST00000379619.1
ENST00000264716.4 |
FOSL2
|
FOS-like antigen 2 |
chr7_+_74188309 | 1.45 |
ENST00000289473.4
ENST00000433458.1 |
NCF1
|
neutrophil cytosolic factor 1 |
chrX_-_10645773 | 1.41 |
ENST00000453318.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr12_+_96588143 | 1.41 |
ENST00000228741.3
ENST00000547249.1 |
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr8_+_6565854 | 1.41 |
ENST00000285518.6
|
AGPAT5
|
1-acylglycerol-3-phosphate O-acyltransferase 5 |
chr2_+_173600671 | 1.38 |
ENST00000409036.1
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr9_-_111882195 | 1.37 |
ENST00000374586.3
|
TMEM245
|
transmembrane protein 245 |
chr6_+_25279651 | 1.37 |
ENST00000329474.6
|
LRRC16A
|
leucine rich repeat containing 16A |
chr4_-_152147579 | 1.35 |
ENST00000304527.4
ENST00000455740.1 ENST00000424281.1 ENST00000409598.4 |
SH3D19
|
SH3 domain containing 19 |
chr11_-_116968987 | 1.33 |
ENST00000434315.2
ENST00000292055.4 ENST00000375288.1 ENST00000542607.1 ENST00000445177.1 ENST00000375300.1 ENST00000446921.2 |
SIK3
|
SIK family kinase 3 |
chr20_+_1246908 | 1.32 |
ENST00000381873.3
ENST00000381867.1 |
SNPH
|
syntaphilin |
chr14_-_75593708 | 1.31 |
ENST00000557673.1
ENST00000238616.5 |
NEK9
|
NIMA-related kinase 9 |
chr1_+_178694300 | 1.30 |
ENST00000367635.3
|
RALGPS2
|
Ral GEF with PH domain and SH3 binding motif 2 |
chr19_-_31840438 | 1.29 |
ENST00000240587.4
|
TSHZ3
|
teashirt zinc finger homeobox 3 |
chr1_-_1624083 | 1.28 |
ENST00000378662.1
ENST00000234800.6 |
SLC35E2B
|
solute carrier family 35, member E2B |
chrX_+_105066524 | 1.26 |
ENST00000243300.9
ENST00000428173.2 |
NRK
|
Nik related kinase |
chr4_-_85887503 | 1.26 |
ENST00000509172.1
ENST00000322366.6 ENST00000295888.4 ENST00000502713.1 |
WDFY3
|
WD repeat and FYVE domain containing 3 |
chr20_-_36156125 | 1.25 |
ENST00000397135.1
ENST00000397137.1 |
BLCAP
|
bladder cancer associated protein |
chr11_-_73309228 | 1.25 |
ENST00000356467.4
ENST00000064778.4 |
FAM168A
|
family with sequence similarity 168, member A |
chrX_-_34675391 | 1.23 |
ENST00000275954.3
|
TMEM47
|
transmembrane protein 47 |
chr19_+_11200038 | 1.22 |
ENST00000558518.1
ENST00000557933.1 ENST00000455727.2 ENST00000535915.1 ENST00000545707.1 ENST00000558013.1 |
LDLR
|
low density lipoprotein receptor |
chr14_-_91526922 | 1.22 |
ENST00000418736.2
ENST00000261991.3 |
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
chr7_+_106809406 | 1.21 |
ENST00000468410.1
ENST00000478930.1 ENST00000464009.1 ENST00000222574.4 |
HBP1
|
HMG-box transcription factor 1 |
chr1_+_173684047 | 1.21 |
ENST00000546011.1
ENST00000209884.4 |
KLHL20
|
kelch-like family member 20 |
chr9_-_16870704 | 1.21 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chrX_+_28605516 | 1.20 |
ENST00000378993.1
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1 |
chr12_-_53893399 | 1.18 |
ENST00000267079.2
|
MAP3K12
|
mitogen-activated protein kinase kinase kinase 12 |
chr22_-_28197486 | 1.17 |
ENST00000302326.4
|
MN1
|
meningioma (disrupted in balanced translocation) 1 |
chr19_+_17581253 | 1.17 |
ENST00000252595.7
ENST00000598424.1 |
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1 |
chr3_-_141868357 | 1.16 |
ENST00000489671.1
ENST00000475734.1 ENST00000467072.1 ENST00000499676.2 |
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr19_+_10527449 | 1.14 |
ENST00000592685.1
ENST00000380702.2 |
PDE4A
|
phosphodiesterase 4A, cAMP-specific |
chr2_+_198669365 | 1.12 |
ENST00000428675.1
|
PLCL1
|
phospholipase C-like 1 |
chr2_+_16080659 | 1.10 |
ENST00000281043.3
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
chr22_+_40573921 | 1.08 |
ENST00000454349.2
ENST00000335727.9 |
TNRC6B
|
trinucleotide repeat containing 6B |
chr17_-_61920280 | 1.07 |
ENST00000448276.2
ENST00000577990.1 |
SMARCD2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
chr20_-_23402028 | 1.04 |
ENST00000398425.3
ENST00000432543.2 ENST00000377026.4 |
NAPB
|
N-ethylmaleimide-sensitive factor attachment protein, beta |
chr11_-_45687128 | 1.03 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr15_+_39873268 | 1.03 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
chr20_-_36793774 | 1.01 |
ENST00000361475.2
|
TGM2
|
transglutaminase 2 |
chr8_-_81787006 | 1.01 |
ENST00000327835.3
|
ZNF704
|
zinc finger protein 704 |
chr11_+_123396528 | 0.98 |
ENST00000322282.7
ENST00000529750.1 |
GRAMD1B
|
GRAM domain containing 1B |
chr6_-_132272504 | 0.98 |
ENST00000367976.3
|
CTGF
|
connective tissue growth factor |
chr4_-_78740511 | 0.98 |
ENST00000504123.1
ENST00000264903.4 ENST00000515441.1 |
CNOT6L
|
CCR4-NOT transcription complex, subunit 6-like |
chr1_+_93913713 | 0.97 |
ENST00000604705.1
ENST00000370253.2 |
FNBP1L
|
formin binding protein 1-like |
chr4_-_25864581 | 0.96 |
ENST00000399878.3
|
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr10_+_89622870 | 0.95 |
ENST00000371953.3
|
PTEN
|
phosphatase and tensin homolog |
chr10_+_63661053 | 0.94 |
ENST00000279873.7
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like) |
chr16_-_17564738 | 0.93 |
ENST00000261381.6
|
XYLT1
|
xylosyltransferase I |
chr17_-_76356148 | 0.93 |
ENST00000587578.1
ENST00000330871.2 |
SOCS3
|
suppressor of cytokine signaling 3 |
chrX_+_135067576 | 0.91 |
ENST00000370701.1
ENST00000370698.3 ENST00000370695.4 |
SLC9A6
|
solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 |
chr15_-_26108355 | 0.90 |
ENST00000356865.6
|
ATP10A
|
ATPase, class V, type 10A |
chr9_-_79520989 | 0.90 |
ENST00000376713.3
ENST00000376718.3 ENST00000428286.1 |
PRUNE2
|
prune homolog 2 (Drosophila) |
chr11_+_43964055 | 0.90 |
ENST00000528572.1
|
C11orf96
|
chromosome 11 open reading frame 96 |
chr1_-_46598284 | 0.90 |
ENST00000423209.1
ENST00000262741.5 |
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
chr2_+_9346892 | 0.89 |
ENST00000281419.3
ENST00000315273.4 |
ASAP2
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
chr12_-_22697343 | 0.86 |
ENST00000446597.1
ENST00000536386.1 ENST00000396028.2 ENST00000545552.1 ENST00000544930.1 ENST00000333957.4 |
C2CD5
|
C2 calcium-dependent domain containing 5 |
chr15_-_49338748 | 0.85 |
ENST00000559471.1
|
SECISBP2L
|
SECIS binding protein 2-like |
chr15_-_31283798 | 0.85 |
ENST00000435680.1
ENST00000425768.1 |
MTMR10
|
myotubularin related protein 10 |
chr10_+_23728198 | 0.83 |
ENST00000376495.3
|
OTUD1
|
OTU domain containing 1 |
chr14_-_34931458 | 0.83 |
ENST00000298130.4
|
SPTSSA
|
serine palmitoyltransferase, small subunit A |
chr11_-_94964354 | 0.83 |
ENST00000536441.1
|
SESN3
|
sestrin 3 |
chr20_+_306221 | 0.82 |
ENST00000342665.2
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr1_+_220960033 | 0.82 |
ENST00000366910.5
|
MARC1
|
mitochondrial amidoxime reducing component 1 |
chr8_-_29120580 | 0.81 |
ENST00000524189.1
|
KIF13B
|
kinesin family member 13B |
chr5_+_140227048 | 0.81 |
ENST00000532602.1
|
PCDHA9
|
protocadherin alpha 9 |
chr2_+_20646824 | 0.79 |
ENST00000272233.4
|
RHOB
|
ras homolog family member B |
chr5_+_140220769 | 0.78 |
ENST00000531613.1
ENST00000378123.3 |
PCDHA8
|
protocadherin alpha 8 |
chr5_+_140213815 | 0.78 |
ENST00000525929.1
ENST00000378125.3 |
PCDHA7
|
protocadherin alpha 7 |
chr11_-_10315741 | 0.78 |
ENST00000256190.8
|
SBF2
|
SET binding factor 2 |
chr2_-_70475730 | 0.78 |
ENST00000445587.1
ENST00000433529.2 ENST00000415783.2 |
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein |
chr5_+_140248518 | 0.78 |
ENST00000398640.2
|
PCDHA11
|
protocadherin alpha 11 |
chr3_-_44519131 | 0.77 |
ENST00000425708.2
ENST00000396077.2 |
ZNF445
|
zinc finger protein 445 |
chr22_-_24093267 | 0.77 |
ENST00000341976.3
|
ZNF70
|
zinc finger protein 70 |
chr10_+_180987 | 0.75 |
ENST00000381591.1
|
ZMYND11
|
zinc finger, MYND-type containing 11 |
chr5_+_42423872 | 0.75 |
ENST00000230882.4
ENST00000357703.3 |
GHR
|
growth hormone receptor |
chr7_+_12250886 | 0.75 |
ENST00000444443.1
ENST00000396667.3 |
TMEM106B
|
transmembrane protein 106B |
chr7_+_8008418 | 0.73 |
ENST00000223145.5
|
GLCCI1
|
glucocorticoid induced transcript 1 |
chr10_-_30348439 | 0.73 |
ENST00000375377.1
|
KIAA1462
|
KIAA1462 |
chr16_-_77468945 | 0.73 |
ENST00000282849.5
|
ADAMTS18
|
ADAM metallopeptidase with thrombospondin type 1 motif, 18 |
chr9_-_107690420 | 0.72 |
ENST00000423487.2
ENST00000374733.1 ENST00000374736.3 |
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1 |
chr16_-_11350036 | 0.70 |
ENST00000332029.2
|
SOCS1
|
suppressor of cytokine signaling 1 |
chr1_+_87380299 | 0.70 |
ENST00000370551.4
ENST00000370550.5 |
HS2ST1
|
heparan sulfate 2-O-sulfotransferase 1 |
chr12_+_1800179 | 0.70 |
ENST00000357103.4
|
ADIPOR2
|
adiponectin receptor 2 |
chr8_+_70378852 | 0.70 |
ENST00000525061.1
ENST00000458141.2 ENST00000260128.4 |
SULF1
|
sulfatase 1 |
chr7_-_95064264 | 0.69 |
ENST00000536183.1
ENST00000433091.2 ENST00000222572.3 |
PON2
|
paraoxonase 2 |
chr1_+_52682052 | 0.69 |
ENST00000371591.1
|
ZFYVE9
|
zinc finger, FYVE domain containing 9 |
chr12_-_57824739 | 0.69 |
ENST00000347140.3
ENST00000402412.1 |
R3HDM2
|
R3H domain containing 2 |
chr11_+_120207787 | 0.69 |
ENST00000397843.2
ENST00000356641.3 |
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12 |
chr18_+_20513782 | 0.68 |
ENST00000399722.2
ENST00000399725.2 ENST00000399721.2 ENST00000583594.1 |
RBBP8
|
retinoblastoma binding protein 8 |
chr19_-_14629224 | 0.68 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr16_-_4166186 | 0.66 |
ENST00000294016.3
|
ADCY9
|
adenylate cyclase 9 |
chr5_+_140254884 | 0.65 |
ENST00000398631.2
|
PCDHA12
|
protocadherin alpha 12 |
chr6_-_79787902 | 0.65 |
ENST00000275034.4
|
PHIP
|
pleckstrin homology domain interacting protein |
chr13_-_30424821 | 0.65 |
ENST00000380680.4
|
UBL3
|
ubiquitin-like 3 |
chr3_+_61547585 | 0.64 |
ENST00000295874.10
ENST00000474889.1 |
PTPRG
|
protein tyrosine phosphatase, receptor type, G |
chr2_+_204192942 | 0.64 |
ENST00000295851.5
ENST00000261017.5 |
ABI2
|
abl-interactor 2 |
chr1_+_28696111 | 0.64 |
ENST00000373839.3
|
PHACTR4
|
phosphatase and actin regulator 4 |
chr11_+_47279504 | 0.63 |
ENST00000441012.2
ENST00000437276.1 ENST00000436029.1 ENST00000467728.1 ENST00000405853.3 |
NR1H3
|
nuclear receptor subfamily 1, group H, member 3 |
chr3_+_179370517 | 0.63 |
ENST00000263966.3
|
USP13
|
ubiquitin specific peptidase 13 (isopeptidase T-3) |
chr3_-_151176497 | 0.63 |
ENST00000282466.3
|
IGSF10
|
immunoglobulin superfamily, member 10 |
chr20_+_57267669 | 0.62 |
ENST00000356091.6
|
NPEPL1
|
aminopeptidase-like 1 |
chr11_+_120894781 | 0.61 |
ENST00000529397.1
ENST00000528512.1 ENST00000422003.2 |
TBCEL
|
tubulin folding cofactor E-like |
chr10_+_65281123 | 0.61 |
ENST00000298249.4
ENST00000373758.4 |
REEP3
|
receptor accessory protein 3 |
chr2_+_203879568 | 0.61 |
ENST00000449802.1
|
NBEAL1
|
neurobeachin-like 1 |
chr17_+_28705921 | 0.60 |
ENST00000225719.4
|
CPD
|
carboxypeptidase D |
chr3_-_114790179 | 0.60 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr17_-_19771216 | 0.58 |
ENST00000395544.4
|
ULK2
|
unc-51 like autophagy activating kinase 2 |
chr8_-_91658303 | 0.57 |
ENST00000458549.2
|
TMEM64
|
transmembrane protein 64 |
chr6_+_160390102 | 0.57 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
chr18_-_12657988 | 0.57 |
ENST00000410092.3
ENST00000409402.4 |
SPIRE1
|
spire-type actin nucleation factor 1 |
chr7_+_94023873 | 0.57 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
chr7_+_155089486 | 0.57 |
ENST00000340368.4
ENST00000344756.4 ENST00000425172.1 ENST00000342407.5 |
INSIG1
|
insulin induced gene 1 |
chr2_+_134877740 | 0.56 |
ENST00000409645.1
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase |
chr8_-_110660999 | 0.55 |
ENST00000424158.2
ENST00000533895.1 ENST00000446070.2 ENST00000528331.1 ENST00000526302.1 ENST00000433638.1 ENST00000408908.2 ENST00000524720.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
chr19_+_14017003 | 0.54 |
ENST00000318003.7
|
CC2D1A
|
coiled-coil and C2 domain containing 1A |
chr8_-_30891078 | 0.54 |
ENST00000339382.2
ENST00000475541.1 |
PURG
|
purine-rich element binding protein G |
chr15_+_40532058 | 0.53 |
ENST00000260404.4
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6 |
chr11_-_74109422 | 0.53 |
ENST00000298198.4
|
PGM2L1
|
phosphoglucomutase 2-like 1 |
chr19_+_35521572 | 0.52 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr21_-_40685477 | 0.52 |
ENST00000342449.3
|
BRWD1
|
bromodomain and WD repeat domain containing 1 |
chrX_-_18372792 | 0.52 |
ENST00000251900.4
|
SCML2
|
sex comb on midleg-like 2 (Drosophila) |
chr9_-_36400213 | 0.52 |
ENST00000259605.6
ENST00000353739.4 |
RNF38
|
ring finger protein 38 |
chr16_+_3070313 | 0.52 |
ENST00000326577.4
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr9_+_125703282 | 0.52 |
ENST00000373647.4
ENST00000402311.1 |
RABGAP1
|
RAB GTPase activating protein 1 |
chr3_+_57261743 | 0.52 |
ENST00000288266.3
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
chr12_-_118541743 | 0.51 |
ENST00000359236.5
|
VSIG10
|
V-set and immunoglobulin domain containing 10 |
chr1_+_14925173 | 0.51 |
ENST00000376030.2
ENST00000503743.1 ENST00000422387.2 |
KAZN
|
kazrin, periplakin interacting protein |
chr7_+_77469439 | 0.50 |
ENST00000450574.1
ENST00000416283.2 ENST00000248550.7 |
PHTF2
|
putative homeodomain transcription factor 2 |
chr1_+_229406847 | 0.50 |
ENST00000366690.4
|
RAB4A
|
RAB4A, member RAS oncogene family |
chr1_+_52521928 | 0.50 |
ENST00000489308.2
|
BTF3L4
|
basic transcription factor 3-like 4 |
chr3_+_152017181 | 0.50 |
ENST00000498502.1
ENST00000324196.5 ENST00000545754.1 ENST00000357472.3 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr6_+_168841817 | 0.49 |
ENST00000356284.2
ENST00000354536.5 |
SMOC2
|
SPARC related modular calcium binding 2 |
chr1_-_52344471 | 0.49 |
ENST00000352171.7
ENST00000354831.7 |
NRD1
|
nardilysin (N-arginine dibasic convertase) |
chr6_+_35182176 | 0.49 |
ENST00000394681.1
ENST00000274938.7 |
SCUBE3
|
signal peptide, CUB domain, EGF-like 3 |
chr5_-_176889381 | 0.48 |
ENST00000393563.4
ENST00000512501.1 |
DBN1
|
drebrin 1 |
chr2_-_105946491 | 0.48 |
ENST00000393359.2
|
TGFBRAP1
|
transforming growth factor, beta receptor associated protein 1 |
chr1_+_116184566 | 0.48 |
ENST00000355485.2
ENST00000369510.4 |
VANGL1
|
VANGL planar cell polarity protein 1 |
chr9_-_99180597 | 0.48 |
ENST00000375256.4
|
ZNF367
|
zinc finger protein 367 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.7 | GO:0060435 | bronchiole development(GO:0060435) |
1.2 | 3.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
1.1 | 3.2 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) |
1.0 | 4.1 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.9 | 2.7 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.7 | 5.2 | GO:0097338 | response to clozapine(GO:0097338) |
0.7 | 2.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.7 | 2.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 4.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.5 | 1.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.5 | 2.8 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.4 | 1.3 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.4 | 3.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.4 | 3.0 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.4 | 4.1 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 1.4 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.3 | 1.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.3 | 4.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 1.0 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 1.0 | GO:0034059 | response to anoxia(GO:0034059) |
0.3 | 1.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 2.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.3 | 1.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.2 | GO:1905167 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.3 | 1.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 1.6 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.3 | 0.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 1.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 0.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 4.7 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 0.6 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.2 | 0.6 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 0.6 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 2.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 1.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.6 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 2.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.7 | GO:0015917 | aminophospholipid transport(GO:0015917) regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.2 | 2.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.5 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.2 | 0.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 1.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 2.9 | GO:0072178 | negative regulation of keratinocyte proliferation(GO:0010839) nephric duct morphogenesis(GO:0072178) |
0.2 | 0.5 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.2 | 0.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 0.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 1.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.4 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.1 | 2.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 1.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) type B pancreatic cell maturation(GO:0072560) |
0.1 | 0.4 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.1 | 1.6 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 1.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 1.4 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.3 | GO:0090425 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.1 | 0.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.3 | GO:0048627 | myoblast development(GO:0048627) |
0.1 | 1.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 1.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.6 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 1.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 1.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.4 | GO:0035905 | N-terminal peptidyl-lysine acetylation(GO:0018076) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 1.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 1.8 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 1.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.3 | GO:0021650 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
0.1 | 0.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.3 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.1 | 0.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.1 | 1.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 1.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 3.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 1.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 1.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 1.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.7 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.1 | 0.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 1.5 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.2 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 1.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.4 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 2.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.9 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 1.5 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.2 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.0 | 3.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 1.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 1.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.6 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.0 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) |
0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.0 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.0 | 0.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.2 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.0 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 1.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.9 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.0 | 0.3 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.1 | GO:0045875 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) negative regulation of sister chromatid cohesion(GO:0045875) protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.0 | 0.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 1.3 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.0 | 1.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.1 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.0 | 1.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 2.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 2.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 4.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.0 | 0.4 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 0.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 1.4 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.7 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.9 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.3 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.0 | 0.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.7 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 3.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 3.2 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 2.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 3.7 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.0 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.0 | 0.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 1.6 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.3 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.7 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.6 | 3.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.4 | 1.2 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.3 | 4.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 0.8 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 5.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 1.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 2.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.5 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.9 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 4.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.4 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 0.4 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 0.6 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.3 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 4.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.1 | 0.8 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 2.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 3.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 4.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.2 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 1.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 2.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 2.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 1.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.5 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.0 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 6.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 2.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.0 | 2.3 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.5 | 1.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.5 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 2.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 2.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.4 | 2.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 1.2 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 2.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 2.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 0.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 4.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 2.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.7 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.2 | 0.9 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.2 | 4.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.7 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 3.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 1.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.2 | 0.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.2 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 2.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 2.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 2.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 2.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.6 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 1.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 3.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.4 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 3.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 2.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 2.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.5 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.1 | 1.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 1.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 5.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 1.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 1.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0086075 | connexin binding(GO:0071253) gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.0 | 1.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 4.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 1.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 13.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 1.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.4 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 2.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.3 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.0 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 5.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 2.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 9.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 6.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 4.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 6.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 3.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 3.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 2.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 1.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 5.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 4.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 4.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 4.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 2.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 5.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 2.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 1.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 2.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 1.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 4.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 2.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 1.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |